Industry Leaders Fireside Chat: What’s Happened in the Last Year & Where is the Field Headed Next?
- Examining the evolution of the autoimmune cell therapy field over the last year
- Discussing progress across autologous, allogeneic, NK and in vivo modalities to uncover development strategies
- Considering indication selection strategies and the potential for indication diversification beyond lupus
- Exploring the future of the field to effectively scale and commercialise safe, durable therapies